What references and what gold standard should be used to assess myosteatosis in chronic liver disease ?

(2024) Journal of Hepatology — Vol. 81, n° 6, p. e273-e274 (2024)

Files

HeninLanthierMyosteatosisCLDJHepatol2024preprint.pdf
  • Open Access
  • Adobe PDF
  • 6.38 MB

Details

Authors
Abstract
We read Simone Di Cola's recent manuscript with interest. The authors use abdominal computed tomography (CT) scans to analyze muscle changes in cirrhotic patients. This is a very interesting area of research. The authors show that many patients have decreased muscle density and/or muscle surface area, which they call myosteatosis and sarcopenia respectively. However, in addition to the criticism of the cut-offs used, which has already been the subject of a comment, we have a few additional remarks which are important in order to make progress on the subject.
Affiliations

Citations

Henin, G., & Lanthier, N. (2024). What references and what gold standard should be used to assess myosteatosis in chronic liver disease ? Journal of Hepatology, 81(6), e273-e274. https://doi.org/10.1016/j.jhep.2024.07.003 (Original work published 2024)